EcoR1 Capital’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,292,386
| Closed | -$82.5M | – | 46 |
|
|
2025
Q1 | $82.5M | Buy |
1,292,386
+522,386
| +68% | +$33.3M | 4.89% | 7 |
|
|
2024
Q4 | $93.6M | Buy |
+770,000
| New | +$93.6M | 3.54% | 9 |
|
|
2024
Q3 | – | Sell |
-1,407,322
| Closed | -$222M | – | 66 |
|
|
2024
Q2 | $222M | Sell |
1,407,322
-512,513
| -27% | -$81M | 6.8% | 3 |
|
|
2024
Q1 | $249M | Buy |
1,919,835
+1,086,928
| +130% | +$141M | 6.29% | 4 |
|
|
2023
Q4 | $80.3M | Buy |
+832,907
| New | +$80.3M | 2.09% | 14 |
|
|
2023
Q3 | – | Sell |
-3,660,798
| Closed | -$419M | – | 56 |
|
|
2023
Q2 | $419M | Buy |
3,660,798
+661,345
| +22% | +$75.7M | 10.27% | 3 |
|
|
2023
Q1 | $413M | Hold |
2,999,453
| – | – | 13.31% | 2 |
|
|
2022
Q4 | $389M | Hold |
2,999,453
| – | – | 11.83% | 2 |
|
|
2022
Q3 | $332M | Buy |
2,999,453
+131,308
| +5% | +$14.5M | 9.79% | 3 |
|
|
2022
Q2 | $215M | Buy |
2,868,145
+798,511
| +39% | +$59.9M | 7.42% | 3 |
|
|
2022
Q1 | $162M | Buy |
+2,069,634
| New | +$162M | 5.06% | 5 |
|
|
2019
Q4 | – | Sell |
-189,745
| Closed | -$14.3M | – | 52 |
|
|
2019
Q3 | $14.3M | Buy |
+189,745
| New | +$14.3M | 1.8% | 15 |
|